Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
SVCCU
Valuation N/A
Stellar V Capital Corp. (Cayman Islands)
Price$10.86
Model IV—
P/IV—
Limited data — see page
SVCCW
Valuation N/A
Stellar V Capital Corp. (Cayman Islands)
Price$0.25
Model IV—
P/IV—
Limited data — see page
SVCO
Valuation N/A
Silvaco Group, Inc.
Price$8.13
Model IV—
P/IV—
Market implies +21.8%/yr
SVIV
Valuation N/A
Spring Valley Acquisition Corp. IV
Price$10.09
Model IV—
P/IV—
Limited data — see page
SVIVU
Valuation N/A
Spring Valley Acquisition Corp. IV
Price$10.20
Model IV—
P/IV—
Limited data — see page
SVIVW
Valuation N/A
Spring Valley Acquisition Corp. IV
Price$0.62
Model IV—
P/IV—
Limited data — see page
SVREW
Valuation N/A
SaverOne 2014 Ltd.
Price$0.01
Model IV—
P/IV—
Market implies +60.0%/yr
SVRN
Valuation N/A
OceanPal Inc.
Price$44.00
Model IV—
P/IV—
Market implies +34.4%/yr
vs model +15.0% · above model
SWAG
Deeply undervalued
Stran & Company, Inc.
Price$1.39
Model IV$15.29
P/IV0.10
Discount 91%
Return to IV: +999.6%
Market implies -50.0%/yr
vs model +30.8% · below model
SWAGW
Valuation N/A
Stran & Company, Inc.
Price$0.00
Model IV—
P/IV—
Market implies -50.0%/yr
SWVL
Valuation N/A
Swvl Holdings Corp
Price$3.92
Model IV—
P/IV—
Limited data — see page
SWVLW
Valuation N/A
Swvl Holdings Corp
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr
SWZ
Valuation N/A
Total Return Securities Fund
Price$5.78
Model IV—
P/IV—
Limited data — see page
SXTC
Valuation N/A
China SXT Pharmaceuticals, Inc.
Price$0.15
Model IV—
P/IV—
Market implies -18.8%/yr
vs model +2.0% · below model
SXTP
Deeply undervalued
60 DEGREES PHARMACEUTICALS, INC.
Price$0.97
Model IV$4.54
P/IV0.26
Discount 79%
Return to IV: +370.0%
Market implies -29.7%/yr
vs model +50.0% · below model
SY
Deeply overvalued
So-Young International Inc.
Price$2.49
Model IV$0.81
P/IV2.41
Premium +208%
Return to IV: -67.6%
Market implies +20.2%/yr
vs model +2.0% · above model
SYNX
Valuation N/A
Silynxcom Ltd.
Price$0.85
Model IV—
P/IV—
Limited data — see page
SYPR
Deeply undervalued
SYPRIS SOLUTIONS INC
Price$2.06
Model IV$6.71
P/IV0.49
Discount 69%
Return to IV: +225.6%
Market implies -23.6%/yr
vs model +5.3% · below model
SZZL
Valuation N/A
Sizzle Acquisition Corp. II
Price$10.50
Model IV—
P/IV—
Limited data — see page
SZZLR
Valuation N/A
Sizzle Acquisition Corp. II
Price$0.13
Model IV—
P/IV—
Limited data — see page
SZZLU
Valuation N/A
Sizzle Acquisition Corp. II
Price$10.54
Model IV—
P/IV—
Limited data — see page
TACH
Valuation N/A
Titan Acquisition Corp.
Price$10.54
Model IV—
P/IV—
Limited data — see page
TACHU
Valuation N/A
Titan Acquisition Corp.
Price$10.75
Model IV—
P/IV—
Limited data — see page
TACHW
Valuation N/A
Titan Acquisition Corp.
Price$0.49
Model IV—
P/IV—
Limited data — see page
TACOW
Valuation N/A
Berto Acquisition Corp.
Price$0.67
Model IV—
P/IV—
Limited data — see page
TACT
Deeply undervalued
TRANSACT TECHNOLOGIES INC
Price$4.49
Model IV$10.65
P/IV0.42
Discount 58%
Return to IV: +137.2%
Market implies -8.3%/yr
vs model +8.5% · below model
TAGS
Valuation N/A
Teucrium Commodity Trust
Price$27.40
Model IV—
P/IV—
Limited data — see page
TALKW
Valuation N/A
TALKW
Price$0.00
Model IV—
P/IV—
Limited data — see page
TANH
Deeply undervalued
TANTECH HOLDINGS LTD
Price$17.01
Model IV$51.38
P/IV0.28
Discount 67%
Return to IV: +202.0%
Market implies -28.6%/yr
vs model +0.9% · below model
TAOP
Undervalued
Taoping Inc.
Price$0.42
Model IV$0.54
P/IV1.18
Discount 22%
Return to IV: +28.6%
Market implies -4.7%/yr
vs model +2.0% · below model
TAOX
Valuation N/A
TAO Synergies Inc.
Price$3.84
Model IV—
P/IV—
Market implies +94.4%/yr
vs model +15.0% · above model
TARA
Valuation N/A
Protara Therapeutics, Inc.
Price$2.76
Model IV—
P/IV—
Limited data — see page
TAVI
Valuation N/A
Tavia Acquisition Corp.
Price$10.78
Model IV—
P/IV—
Limited data — see page
TAVIR
Valuation N/A
Tavia Acquisition Corp.
Price$0.07
Model IV—
P/IV—
Limited data — see page
TAVIU
Valuation N/A
Tavia Acquisition Corp.
Price$10.85
Model IV—
P/IV—
Limited data — see page
TAYD
Fairly valued
TAYLOR DEVICES, INC.
Price$58.92
Model IV$56.24
P/IV0.91
Premium +5%
Return to IV: -4.5%
Market implies +11.9%/yr
vs model +17.6% · below model
TBBB
Valuation N/A
BBB FOODS INC
Price$55.59
Model IV—
P/IV—
Limited data — see page
TBCH
Fairly valued
Turtle Beach Corp
Price$13.24
Model IV$12.09
P/IV1.06
Premium +10%
Return to IV: -8.7%
Market implies +2.6%/yr
vs model +4.2% · in line
TBH
Valuation N/A
Brag House Holdings, Inc.
Price$3.53
Model IV—
P/IV—
Market implies +150.0%/yr
vs model +15.0% · above model
TBI
Deeply undervalued
TrueBlue, Inc.
Price$8.87
Model IV$73.24
P/IV0.08
Discount 88%
Return to IV: +725.8%
Market implies -45.1%/yr
vs model +2.0% · below model
TBLAW
Valuation N/A
TBLAW
Price$0.01
Model IV—
P/IV—
Limited data — see page
TC
Valuation N/A
Token Cat Ltd
Price$1.55
Model IV—
P/IV—
Market implies +46.7%/yr
TCBS
Deeply overvalued
Texas Community Bancshares, Inc.
Price$17.00
Model IV$9.18
P/IV1.82
Premium +85%
Return to IV: -46.0%
TCRT
Valuation N/A
Alaunos Therapeutics, Inc.
Price$0.79
Model IV—
P/IV—
Market implies +80.4%/yr
vs model +2.0% · above model
TCRX
Valuation N/A
TScan Therapeutics, Inc.
Price$0.24
Model IV—
P/IV—
Market implies +56.3%/yr
vs model +2.0% · above model
TCX
Deeply undervalued
TUCOWS INC /PA/
Price$9.14
Model IV$53.41
P/IV0.28
Discount 83%
Return to IV: +484.3%
Market implies -35.6%/yr
vs model +6.4% · below model
TDAC
Valuation N/A
Translational Development Acquisition Corp.
Price$10.82
Model IV—
P/IV—
Limited data — see page
TDACU
Valuation N/A
Translational Development Acquisition Corp.
Price$11.66
Model IV—
P/IV—
Limited data — see page
TDACW
Valuation N/A
Translational Development Acquisition Corp.
Price$1.26
Model IV—
P/IV—
Limited data — see page
TDF
Valuation N/A
TEMPLETON DRAGON FUND INC
Price$9.70
Model IV—
P/IV—
Limited data — see page
TDIC
Valuation N/A
Dreamland Ltd
Price$1.69
Model IV—
P/IV—
Limited data — see page
TDWD
Valuation N/A
Tailwind 2.0 Acquisition Corp.
Price$10.13
Model IV—
P/IV—
Limited data — see page
TDWDR
Valuation N/A
Tailwind 2.0 Acquisition Corp.
Price$0.10
Model IV—
P/IV—
Limited data — see page
TDWDU
Valuation N/A
Tailwind 2.0 Acquisition Corp.
Price$10.18
Model IV—
P/IV—
Limited data — see page
TEAD
Valuation N/A
Teads Holding Co.
Price$0.54
Model IV—
P/IV—
Market implies -50.0%/yr
TEI
Valuation N/A
TEMPLETON EMERGING MARKETS INCOME FUND
Price$6.19
Model IV—
P/IV—
Limited data — see page
TELA
Deeply undervalued
TELA Bio, Inc.
Price$1.11
Model IV$6.38
P/IV0.15
Discount 83%
Return to IV: +474.3%
Market implies -39.8%/yr
vs model +28.5% · below model
TELO
Valuation N/A
Telomir Pharmaceuticals, Inc.
Price$1.12
Model IV—
P/IV—
Limited data — see page
TEM
Valuation N/A
Tempus AI, Inc.
Price$70.93
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +50.0% · below model
TEO
Valuation N/A
TELECOM ARGENTINA SA
Price$12.37
Model IV—
P/IV—
Limited data — see page
